Skip to main content
SpringerLink
Log in

Intensivmedizinische Aspekte der Antibiotikatherapie

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Die Anästhesiologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 397 Accesses

Zusammenfassung

Während viele Maßnahmen in der Intensivmedizin supportiv sind, ermöglichen Antibiotika eine kausale Therapie. Die Auswahl erfolgt jedoch meist vor dem mikrobiologischen Nachweis, sodass sich die kalkulierte Therapie an den wahrscheinlichsten Erregern orientieren muss. Deutliche regionale Unterschiede bedingen, dass für viele Infektionen zwar ein typisches, aber nicht allgemein gültiges Erregerspektrum angegeben werden kann.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  1. Beaucaire C (2000) Does once-daily dosing prevent nephrotoxicity in all Aminoglykosides equally? Clin Microbiol Infect 6:357–362

    Article  CAS  PubMed  Google Scholar 

  2. Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient – concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014 Nov 20:77:3–11

    Google Scholar 

  3. Brunkhorst FM, Oppert M, Marx G et al (2012) Effect of empirical treatment with Moxifloxacin and Meropenem vs Meropenem on sepsis-related organ dysfunction in patientes with severe sepsis. JAMA 307:2390–2399

    Article  CAS  PubMed  Google Scholar 

  4. Cunha BA (1999) Fever in the intensive care unit. Intensive Care Med 25:648–651

    Article  CAS  PubMed  Google Scholar 

  5. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections. Chest 115:462–474

    Article  CAS  PubMed  Google Scholar 

  6. Krueger WA, Ruckdeschel G, Unertl K (1997) Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate. Antimicrob Agents Chemother 41:1725–1730

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Krueger WA, Ruckdeschel G, Unertl K (1999) Elimination of fecal Enterobacteriaceae by intravenous ciprofloxacin is not inhibited by concomitant sucralfate – a microbiological and pharmacokinetic study in patients. Infection 27:335–340

    Article  CAS  PubMed  Google Scholar 

  8. Krueger WA, Bulitta J, Kinzig-Schippers M et al (2005) Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers. Antimicrob Agents Chemother 49:1881–1889

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596

    Article  PubMed  Google Scholar 

  10. Lemmen SW, Engels I, Daschner FD (1997) Serum bactericidal activity of ceftazidime administered as continuous infusion of 3 g over 24 h vs. intermittent bolus infusion of 2 g against Pseudomonas aeruginosa in healthy volunteers. J Antimicrob Chemother 39:841–842

    Article  CAS  PubMed  Google Scholar 

  11. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328:668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J (2007) Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int J Antimicrob Agents 30:11–18

    Article  CAS  PubMed  Google Scholar 

  13. Roberts JA, Abdul-Aziz MH, Lipman J et al (2014) Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis 14:498–509

    Article  PubMed  PubMed Central  Google Scholar 

  14. Weinstein RA (1986) Endemic emergence of resistance of cephalosporin-resistant enterobacter: relation to prior therapy. Infect Control 7:120–123

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Uniklinik RWTH Aachen, Zentralbereich für Krankenhaushygiene und Infektiologie, Pauwelsstr. 30, 52074, Aachen, Deutschland

    Sebastian Lemmen & Karl Lewalter

  2. Klinikum Konstanz, Klinik für Anaesthesiologie und Operative Intensivmedizin, Luisenstr. 7, 78464, Konstanz, Deutschland

    Wolfgang Krüger

Authors
  1. Sebastian Lemmen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Lewalter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolfgang Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Lemmen .

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, Universitätsklinikum Aachen RWTH Aachen, Aachen, Germany

    Rolf Rossaint

  2. Universitätsklinikum Mainz Klinik für Anästhesiologie, Mainz, Germany

    Christian Werner

  3. Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum München Klinikum Großhadern, München, Germany

    Bernhard Zwißler

Section Editor information

  1. Klinik für operative Intensivmedizin und Intermediate Care, Universitätsklinikum Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland

    Rolf Rossaint

Rights and permissions

Reprints and permissions

Copyright information

© 2018 © Springer-Verlag GmbH Deutschland

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Lemmen, S., Lewalter, K., Krüger, W. (2018). Intensivmedizinische Aspekte der Antibiotikatherapie. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_139-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45539-5_139-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45539-5

  • Online ISBN: 978-3-662-45539-5

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Intensivmedizinische Aspekte der Antibiotikatherapie
    Published:
    15 March 2018

    DOI: https://doi.org/10.1007/978-3-662-45539-5_139-2

  2. Original

    Intensivmedizinische Aspekte der Antibiotikatherapie
    Published:
    20 April 2017

    DOI: https://doi.org/10.1007/978-3-662-45539-5_139-1

Search

Navigation